Investing-News.Com
Information for Investors

BRISTOL MYERS SQI, (BMY) Stock Research - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

BRISTOL MYERS SQI, (BMY) Stock Research Free Stock Rating

 
Company Profile
 
Bristol-Myers Squibb Company (BMS) engages in the discovery, development, license, manufacture, marketing, distribution, and sale of pharmaceutical and other health care products. The company primarily operates in three segments: Pharmaceuticals, Nutritionals, and Other Healthcare. The Pharmaceuticals segment provides branded pharmaceutical products for cardiovascular, virology, including human immunodeficiency virus, infectious diseases, oncology, affective disorders, and metabolics. It offers its products primarily to wholesalers, retail pharmacies, hospitals, government entities, and the medical professionals. The Nutritionals segment manufactures, markets, distributes, and sells infant formulas and other nutritional products, including a line of ENFAMIL products. The nutritional products are generally sold by wholesalers and retailers to healthcare professionals. The company’s Other Healthcare segment consists of ConvaTec, Medical Imaging, and Consumer Medicines businesses. ConvaTec provides ostomy, and wound and skin care products. Medical Imaging offers cardiovascular imaging products, including radiopharmaceuticals and ultra-sound agents. Consumer Medicines provides consumer health care products for headache relief, analgesics, cold, cough, flu, and moisturizers, as well as for diabetics. BMS has strategic alliances with Sanofi-Aventis; Otsuka Pharmaceutical Co., Ltd.; ImClone Systems Incorporated; and Sankyo Company, Ltd. The company through a collaboration agreement with Merck & Co., Inc. codevelops and copromotes muraglitazar, its dual peroxisome proliferator activated receptor agonist. The company was incorporated in 1933 under the name Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers is headquartered in the New York City.

BRISTOL MYERS SQI Related

BMY: Summary for BRISTOL MYERS SQIBB - Yahoo! Finance Get detailed information on BRISTOL MYERS SQIBB (BMY) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the ...
Stock Research (BMY) Bristol Myers Sqi ~ One Stop Shop for Investing ... Bristol Myers Sqi BMY Research, The Best Investing Resources For Any Trader! ... How to trade Bristol Myers Sqi for the Long Term The Position Cost Averaging ...
Bolsa PT - Notícias de BRISTOL MYERS SQI [BMY] Bolsa PT - Notícias de BRISTOL MYERS SQI [BMY], Resumo, Cotações, Notícias, Fórum, Chat, Tickers, Históricos... à acção BRISTOL MYERS SQI (ordenadas pela ...
Sponsored Links:

Software Forces BRISTOL MYERS SQI Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in BRISTOL MYERS SQI buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on BRISTOL MYERS SQI. This software is specially designed to give precision entry and exit points on BRISTOL MYERS SQI, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When BRISTOL MYERS SQI Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even BRISTOL MYERS SQI, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: 3m ceo replace mcnerney quaker pepsico  online trading technique  employee stock options  2nd quarter 2005 stock market commentary  investing company 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Cash-Rich Drugmakers Eye Mergers or Acquisitions (BusinessWeek)

UPDATE - AstraZeneca to cut jobs, halts generic asthma drug (at Reuters)

Markets Strike Fresh Lows (at Seeking Alpha)

Bristol-Myers Squibb Could Rise To Old Highs (at Investopedia)

Final Glance: Pharmaceuticals companies (AP)

Depressing News for Drugmakers (at Motley Fool)

International pharma group names leadership (AP)

[video] Shocker Stock: Gilead (at TheStreet.com)

Midday Glance: Pharmaceuticals companies (AP)

The Most Generous Companies (at Motley Fool)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.